Clinical Trial Update: Acalabrutinib in Patients With Chronic Lymphocytic Leukemia With Direct Oral Anticoagulation (CICERO)

View source ↗

Summary

An ongoing clinical trial evaluating acalabrutinib in chronic lymphocytic leukemia patients taking direct oral anticoagulants; the study is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CALQUENCE (ACALABRUTINIB)

Snippet

Sponsor: iOMEDICO AG | Conditions: CLL | Status: ACTIVE_NOT_RECRUITING